Poziotinib hydrochloride
Poziotinib hydrochloride irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. It is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity.
Product Specifications
CAS Number
1429757-68-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
527.8
Molecular Formula
C23H22Cl3FN4O3
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog